Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
6
×
fda
6
×
life sciences
national blog main
boston top stories
clinical trials
new york blog main
new york top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
europe blog main
biogen
blueprint medicines
cancer drugs
deerfield management
drug discovery
eli lilly
europe top stories
What
ipo
6
×
medicines
bio
companies
new
roundup
covid
life
science
sciences
therapeutics
week
acquisitions
activity
announced
approvals
arena’s
biogen
biotech
biotechs
black
bounty
cancer
ceo
cig
clamped
clinic
club
collabs
comeback
company’s
continued
corner
course
crop
daniel
deal
deals
delays
delivered
Language
unset
Current search:
ipo
×
fda
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M